ARD

Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding

Retrieved on: 
Monday, March 11, 2024
Natural science, Pharmacology, Pharmacy, Research, College, Biotechnology, SSI, Partnership, Ageing, News, Humanities, PI, Christianity in Singapore, Engineering Council, Innovation, Technology Center, Engineering, Patient, CCI, Public, Site, Liver disease, Social science, ARD, Pharmaceutical industry

TransBIOTech, a dedicated Applied Research and Technology Center in Quebec that is focused on supporting biotechnology companies and deepening expertise in this sector in Canada, will partner on this work.

Key Points: 
  • TransBIOTech, a dedicated Applied Research and Technology Center in Quebec that is focused on supporting biotechnology companies and deepening expertise in this sector in Canada, will partner on this work.
  • Dr. Shirin Kalyan, Immunologist and Qu’s Vice President of Scientific Innovation, stated, “In partnership with TransBIOTech, we are very pleased to have been awarded this Applied Research and Development grant to support the expansion of our preclinical and translational programs while we [Qu Biologics] focus on completing enrollment of our two important Phase 2 clinical trials currently underway.
  • We at TransBIOTech aim to nurture the Canadian biotech ecosystem and to help generate value for innovative Canadian biotechnology companies, such as Qu Biologics.
  • Please subscribe here to receive future news and updates from Qu Biologics.

KBRA Assigns Preliminary Rating to Kobalt Music Assets LP, Series 2024-1

Retrieved on: 
Tuesday, February 20, 2024
Entertainment, Professional Services, Music, Finance, ABS, YoungBoy Never Broke Again, Series, Valuation, KBRA, Catalog, AJR, Kobalt, Note, ARD, Telescopic sight

KBRA assigns preliminary rating to one class of notes issued by Kobalt Music Assets LP, Series 2024-1 (Kobalt 2024-1), a music royalty ABS transaction.

Key Points: 
  • KBRA assigns preliminary rating to one class of notes issued by Kobalt Music Assets LP, Series 2024-1 (Kobalt 2024-1), a music royalty ABS transaction.
  • Kobalt Music Assets LP (the Issuer) represents Kobalt Music Group’s first music royalty securitization.
  • Royalty payments from the Catalog are all from musical compositions and musical publishing rights.
  • An independent third-party valuation firm determined a valuation of $410.0 million as of September 30, 2023 for the Catalog using a discounted cash flow method.

National Academy of Medicine Member New President of The Obesity Society

Retrieved on: 
Thursday, February 1, 2024
Bias, The Obesity Society, Medical school, Growth, University, Metabolism, Science, Obesity, Duke University Hospital, Division, Society, National academy, Patient, Inborn errors of metabolism, Columbia University, Wellness, Executive Committee, ARD, Obesity medicine, Harvard Medical School, Education, Health equity, Doctor of Philosophy, Health, Cornier, Cedars-Sinai Medical Center, Clinical research, Internal medicine

ROCKVILLE, Md. , Feb. 1, 2024 /PRNewswire/ -- A member of the National Academy of Medicine is the new president of The Obesity Society (TOS), the organization announced today.

Key Points: 
  • , Feb. 1, 2024 /PRNewswire/ -- A member of the National Academy of Medicine is the new president of The Obesity Society (TOS), the organization announced today.
  • He also co-directs the Atrium Health Wake Forest Baptist Weight Management Center, where he oversees medical weight management programs.
  • "I am honored to serve as president of TOS during such a transformative time in the field of obesity.
  • The Obesity Society (TOS) is the leading organization of scientists and health professionals devoted to understanding and reversing the epidemic of obesity and its adverse health, economic and societal effects.

Accusations against Hubert Seipel: NDR examines legal action

Retrieved on: 
Wednesday, November 15, 2023
ARD, Disclosure, NDR, Seipel, Film industry, Portrait, Spiegel

HAMBURG, Germany, Nov. 15, 2023 /PRNewswire/ -- Following a press inquiry on November 6, NDR was confronted with serious allegations against documentary filmmaker Hubert Seipel.

Key Points: 
  • HAMBURG, Germany, Nov. 15, 2023 /PRNewswire/ -- Following a press inquiry on November 6, NDR was confronted with serious allegations against documentary filmmaker Hubert Seipel.
  • At the time, Seipel did not inform NDR that he had secured these contracts.
  • We are looking into this now and are considering legal action.
  • We will thoroughly examine the procedures surrounding the commissioning and production of the films Hubert Seipel made for NDR.

Accusations against Hubert Seipel: NDR examines legal action

Retrieved on: 
Wednesday, November 15, 2023
ARD, Disclosure, NDR, Seipel, Film industry, Portrait, Spiegel

HAMBURG, Germany, Nov. 15, 2023 /PRNewswire/ -- Following a press inquiry on November 6, NDR was confronted with serious allegations against documentary filmmaker Hubert Seipel.

Key Points: 
  • HAMBURG, Germany, Nov. 15, 2023 /PRNewswire/ -- Following a press inquiry on November 6, NDR was confronted with serious allegations against documentary filmmaker Hubert Seipel.
  • At the time, Seipel did not inform NDR that he had secured these contracts.
  • We are looking into this now and are considering legal action.
  • We will thoroughly examine the procedures surrounding the commissioning and production of the films Hubert Seipel made for NDR.

CHiQ Showcases User-Centric Innovations at 2023 IFA

Retrieved on: 
Monday, September 4, 2023
Television, Apple TV, Food preservation, Changhong, Temperature, Roku, Amazon, ZDF, Freezing, OLED, ARD, Netflix, CHNW-FM, Esports

BERLIN, Sept. 4, 2023 /PRNewswire/ -- CHiQ held a new product launch event at IFA in Berlin on September 1, 2023, with TVs, monitors, refrigerators and washing machines making a stunning debut, highlighting the brand's fresh momentum.

Key Points: 
  • BERLIN, Sept. 4, 2023 /PRNewswire/ -- CHiQ held a new product launch event at IFA in Berlin on September 1, 2023, with TVs, monitors, refrigerators and washing machines making a stunning debut, highlighting the brand's fresh momentum.
  • In addition, starting from October 2023, several CHiQ TVs equipped with the latest Roku OS will be available in Europe.
  • CHiQ is rapidly carving out a space in the European market, establishing a presence on mainstream e-commerce platforms in many countries.
  • "Smart with Style" is the new brand proposition of CHiQ, aiming to blend intelligent technologies with stylish designs for an integrated home environment.

CHiQ Showcases User-Centric Innovations at 2023 IFA

Retrieved on: 
Monday, September 4, 2023
Television, Apple TV, Food preservation, Changhong, Multimedia, Temperature, Roku, Amazon, ZDF, Freezing, OLED, ARD, Netflix, Mobile phone, Online shopping, CHNW-FM, Esports

BERLIN, Sept. 4, 2023 /PRNewswire/ -- CHiQ held a new product launch event at IFA in Berlin on September 1, 2023, with TVs, monitors, refrigerators and washing machines making a stunning debut, highlighting the brand's fresh momentum.

Key Points: 
  • BERLIN, Sept. 4, 2023 /PRNewswire/ -- CHiQ held a new product launch event at IFA in Berlin on September 1, 2023, with TVs, monitors, refrigerators and washing machines making a stunning debut, highlighting the brand's fresh momentum.
  • In addition, starting from October 2023, several CHiQ TVs equipped with the latest Roku OS will be available in Europe.
  • CHiQ is rapidly carving out a space in the European market, establishing a presence on mainstream e-commerce platforms in many countries.
  • "Smart with Style" is the new brand proposition of CHiQ, aiming to blend intelligent technologies with stylish designs for an integrated home environment.

Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345

Retrieved on: 
Wednesday, July 5, 2023
Vaccine, Biologics license application, MRNA, Urinary tract infection, Therapy, Public, Biotechnology, European Medicines Agency, Cancer, Therapeutic Goods Administration, Licensure, RNA, Messenger, EMA, RSV, European, Ageing, TGA, FDA, ARD, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, BLA, Food, Disease, Pharmaceutical industry, Moderna, Swissmedic

The ConquerRSV study is ongoing, and additional efficacy analyses are planned as cases accrue, including for severe RSV.

Key Points: 
  • The ConquerRSV study is ongoing, and additional efficacy analyses are planned as cases accrue, including for severe RSV.
  • In addition to older adults, mRNA-1345 is being investigated in a fully enrolled, ongoing Phase 1 trial in pediatric populations.
  • Moderna's respiratory disease vaccine pipeline includes Phase 3 trials against influenza and a next-generation COVID-19 candidate.
  • The pipeline also includes four additional influenza vaccines with expanded antigens, vaccines against other respiratory pathogens, and five combination vaccine programs.

Center for Asbestos Related Disease (CARD) Forms Scientific Advisory Group

Retrieved on: 
Monday, June 19, 2023
CARD, Asbestos-related diseases, University, Epidemiology, COVID-19, Scientific Advisory Group, Research, Montana State University, Autoimmunity, Creativity, Radiology, SAG, Outline, Asbestos, Center of excellence, The Humble Guys, Mortality, ARD, Cornell University, Montana House of Representatives, Pharmaceutical industry

LIBBY, Mont., June 19, 2023 /PRNewswire/ -- The Center for Asbestos Related Disease (CARD) was designated a Center of Excellence by the Montana House of Representatives Resolution HR-2 in April and, in response, CARD has established a Scientific Advisory Group (SAG) to assist in guiding the organization as it moves forward.

Key Points: 
  • LIBBY, Mont., June 19, 2023 /PRNewswire/ -- The Center for Asbestos Related Disease (CARD) was designated a Center of Excellence by the Montana House of Representatives Resolution HR-2 in April and, in response, CARD has established a Scientific Advisory Group (SAG) to assist in guiding the organization as it moves forward.
  • The group includes radiologists, a pulmonologist, occupational medicine specialists, epidemiologists, an immunotoxicologist, and a medical imaging analyst.
  • At the SAG formation session held in April, the group came together to outline what it hoped to accomplish over the next 24 months.
  • CARD is humbled and excited to enter this new chapter and expand its expertise through collaboration with these highly respected individuals.

A Simple Antibacterial Treatment Solves a Severe Skin Problem Caused by Radiation Therapy

Retrieved on: 
Thursday, May 4, 2023
Albert Einstein College of Medicine, Infection, Skin infection, Radiation, MECC, Neoplasm, Dermatitis, Sore, Cancer, Quality of life, MacLellan, Staphylococcus aureus, Nose, JAMA Oncology, Dermatology, Mupirocin, Montefiore Medical Center, Standard of care, Swelling, Risk, Breast, B.A, Bacteria, Severity, SA, ARD, News, Skin, Breast cancer, Medical imaging, Pharmaceutical industry, Poultry farming, Patient, Aquaphor

BRONX, N.Y., May 4, 2023 /PRNewswire/ -- Acute radiation dermatitis (ARD)—characterized by red, sore, itchy or peeling skin—affects up to 95% of people undergoing radiation treatment for cancer. Severe cases can cause significant swelling and painful skin ulcers that can severely impair quality of life, yet little is known about why this condition occurs and no standardized treatments for preventing severe ARD have been widely adapted.

Key Points: 
  • Researchers at Montefiore Einstein Cancer Center (MECC) have found that many cases of ARD involve a common skin bacterium and that a simple, low-cost treatment can prevent severe cases, potentially setting a new standard of care for people undergoing radiation therapy.
  • Each year, 10 million people are treated with radiation therapy to reduce the size of their tumors.
  • Radiation weakens the skin's structure at the treatment site and can result in infection by allowing SA to break through the skin's outer layer.
  • In one of the JAMA Oncology studies, the MECC researchers enrolled 76 patients undergoing radiation therapy for cancer.